We are live on ! Find out more
UL

Ulys LLC Portfolio holdings

AUM $25.4M
1-Year Est. Return 201.03%
This Fund
S&P 500
This Quarter Est. Return
+9.64%
1 Year Est. Return
+201.03%
3 Year Est. Return
-31.51%
5 Year Est. Return
-50.88%
10 Year Est. Return
–
AUM
$70.9M
AUM Growth
+$6.2M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 99.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LXRX icon
1
Lexicon Pharmaceuticals
LXRX
$1.04B
$70.9M 99.94%
4,254,658
– –
CERE
2
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
$46K 0.06%
3,891
– –

Similar funds

WSC
White Square Capital London, United Kingdom $14.7M AUM 151.72% 1-Year Est. Return
AGEC
Ark Global Emerging Companies Salt Lake City, Utah $14M AUM
OHS
Odey Holdings (Switzerland) Zurich, Switzerland, Switzerland $11.1M AUM 64.12% 1-Year Est. Return
LW
LLR Walnut Philadelphia, Pennsylvania $10M AUM 71.21% 1-Year Est. Return
PCG
Park Capital Group Redondo Beach, California $8.62M AUM
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
EFM
Ennismore Fund Management London, United Kingdom $71.7M AUM 92.16% 1-Year Est. Return
NI
Northwood Investors Denver, Colorado $73.8M AUM

Ulys LLC's Q3 2013 Portfolio in Review

As of Q3 2013, Ulys LLC held 2 positions worth $70.9M, up 9.6% from $64.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2013: portfolio turnover was 0%. Ulys LLC opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier.

  • Ulys LLC's ten largest holdings make up 100% of its $70.9M portfolio in Q3 2013.
  • Ulys LLC opened 0 new positions and closed 0 in Q3 2013.
  • Ulys LLC's portfolio value rose 9.6% quarter-over-quarter to $70.9M.

Based on Ulys LLC's 13F filing for Q3 2013, filed 14 Nov 2013.